Cedilla Therapeutics
Founded
2018
2018
Geography
United States of America based
United States of America based
Funding
$56.200 M
$56.200 M
Website
https://www.cedillatx.com/
https://www.cedillatx.com/
Cedilla is harnessing intrinsic protein stability mechanisms to broaden the reach of small molecule therapeutics. They work on cancer and other diseases caused by protein dysregulation.
Technologies
Protein Degraders StartupsPosts Mentioning This Company
R&D Platform
-
Pipelines
Transcription Factor Precision Therapeutic
Preclinical
|
Visit website
Cedilla is developing novel small-molecule therapeutics directed to unrecognized allosteric binding sites, providing new ways to target key cancer drivers and treat life threatening diseases.
Products
Services
No services posted yet
